Blured Pharmaceuticals Private Limited

Veterinary medicine and feed supplement manufacturer, distributor, and supplier since 2015 in Tamil Nadu.

2015 | Vellore, Tamil Nadu (India) | Active
Last Updated:

Blured Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 5.00 Cr
  • Paid Up Capital ₹ 3.28 Cr
  • Company Age 9 Year, 6 Months
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth -12.07%
  • Profit Growth -39.07%
  • Ebitda -58.20%
  • Net Worth -0.31%
  • Total Assets 6.78%

About Blured Pharmaceuticals

Blured Pharmaceuticals Private Limited (BPPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 August 2015 (Nine years and six months 25 days old ). Its registered office is in Vellore, Tamil Nadu, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 3.28 Cr, as per Ministry of Corporate Affairs (MCA) records.

Subramaniyan Balanagarajan and Jayakumar Sadhanandam serve as directors at the Company.

Company Details

  • Location

    Vellore, Tamil Nadu, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24100TN2015PTC101840

  • Company No.

    101840

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    17 Aug 2015

  • Date of AGM

    29 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Chennai

Industry

Pharma

What products or services does Blured Pharmaceuticals Private Limited offer?

Blured Pharmaceuticals Private Limited offers a wide range of products and services, including Animal Medicines & Health Care, Veterinary Medicines, Common Disease Medicines, Injectable Products, Plastic Containers & Bottles, Chemical Bottle.

Who are the key members and board of directors at Blured Pharmaceuticals?

Board Members (2)

NameDesignationAppointment DateStatus
Subramaniyan Balanagarajan Country flag representing In Director 28-Nov-2021Current
Jayakumar Sadhanandam Country flag representing In Director 31-May-2019Current

Financial Performance of Blured Pharmaceuticals.

Blured Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 12.07% decrease. The company also saw a substantial fall in profitability, with a 39.07% decrease in profit. The company's net worth dipped by a decrease of 0.31%.

Blured Pharmaceuticals revenue growth over time
Blured Pharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-12.07%
Revenue from Operations
-12.27%
Total Assets
6.78%
Profit or Loss
-39.07%
Net Worth
-0.31%
EBITDA
-58.20%

What is the Ownership and Shareholding Structure of Blured Pharmaceuticals?

In 2023, Blured Pharmaceuticals had a promoter holding of 1.83% and a public holding of 98.17%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Blured Pharmaceuticals?

Unlock and access historical data on people associated with Blured Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Blured Pharmaceuticals Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Blured Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Blured Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Blured Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    Blured Pharmaceuticals Private Limited last Annual general meeting of members was held on 29 Sep 2024 as per latest MCA records.

  • Balance Sheet

    Blured Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai.

  • Director Appointment

    Subramaniyan Balanagarajan was appointed as a Director was appointed as a Director on 28 Nov 2021 & has been associated with this company since 3 years 3 months .

  • Director Appointment

    Jayakumar Sadhanandam was appointed as a Director was appointed as a Director on 31 May 2019 & has been associated with this company since 5 years 9 months .

  • Company Incorporation

    Blured Pharmaceuticals Private Limited was registered on 17 Aug 2015 with Roc Chennai & aged 9 years 6 months as per MCA records.

Frequently asked questions

  • What is the Incorporation or founding date of Blured Pharmaceuticals Private Limited?

    Blured Pharmaceuticals Private Limited was incorporated on 17 Aug 2015.

  • What is authorized share capital and paid-up capital of Blured Pharmaceuticals Private Limited?

    The authorized share capital of Blured Pharmaceuticals Private Limited is ₹ 5.00 Cr and paid-up capital is ₹ 3.28 Cr.

  • Who are the current board members & directors of Blured Pharmaceuticals Private Limited?

    Currently 2 directors are associated with Blured Pharmaceuticals Private Limited.

    • Subramaniyan Balanagarajan
    • Jayakumar Sadhanandam

  • What is the registered address of Blured Pharmaceuticals Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Blured Pharmaceuticals Private Limited is Door No 140 Bazaar Street Vazhaipandal, Ranipet District India, Arcot, Tamil Nadu, 632318.

  • What is the corporate identification number (CIN) and company number of Blured Pharmaceuticals Private Limited?

    The corporate identification number (CIN) of Blured Pharmaceuticals Private Limited is U24100TN2015PTC101840 and the company number is 101840 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Blured Pharmaceuticals Private Limited?

    The Official website of Blured Pharmaceuticals Private Limited is https://www.bluredpharma.com

  • What has been the recent revenue trend for Blured Pharmaceuticals Private Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Blured Pharmaceuticals Private Limited has fallen by -12.07%.

  • What change has been observed in the net worth of Blured Pharmaceuticals Private Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Blured Pharmaceuticals Private Limited has experienced an downturn of -0.31%.

  • When was the last Balance Sheet of Blured Pharmaceuticals Private Limited filed with the ROC?

    The most recent Balance Sheet for Blured Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.

People also Viewed

Similar Companies Based on Pharmaceutical Retailers & Distributors